Skip to content
10-K

Annual Report

Protea Biosciences Group, Inc.

0001144204-17-020500

← back to feed
Filed
Apr 14, 2017 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · Apr 13, 2017 209.92M sh
Cash And Equivalents FY 2016 · Dec 31, 2016 $78.72K
Cash And Equivalents FY 2016 · Dec 31, 2015 $6.45K
Cash And Equivalents FY 2016 · Dec 31, 2014 $322.88K
Stockholders Equity FY 2016 · Dec 31, 2016 −$14.11M
Stockholders Equity FY 2016 · Dec 31, 2015 −$8.27M
Stockholders Equity FY 2016 · Dec 31, 2014 −$5.55M
Current Liabilities FY 2016 · Dec 31, 2016 $15.55M
Current Liabilities FY 2016 · Dec 31, 2015 $9.59M
Current Assets FY 2016 · Dec 31, 2016 $728.92K
Current Assets FY 2016 · Dec 31, 2015 $411.59K
Total Assets FY 2016 · Dec 31, 2016 $3.21M
Total Assets FY 2016 · Dec 31, 2015 $3.04M
Sga Expense FY 2016 · Dec 31, 2016 $5.63M
Sga Expense restated FY 2016 · Dec 31, 2015 $6.92M
Rd Expense FY 2016 · Dec 31, 2016 $602.27K
Rd Expense restated FY 2016 · Dec 31, 2015 $1.34M
Net Income FY 2016 · Dec 31, 2016 −$15.65M
Net Income FY 2016 · Dec 31, 2015 −$9.57M
Operating Income FY 2016 · Dec 31, 2016 −$5.49M
Operating Income FY 2016 · Dec 31, 2015 −$7.14M
Gross Profit FY 2016 · Dec 31, 2016 $741.03K
Gross Profit restated FY 2016 · Dec 31, 2015 $1.12M
Cost Of Revenue FY 2016 · Dec 31, 2016 $1.71M
Cost Of Revenue restated FY 2016 · Dec 31, 2015 $740.83K